Quince Therapeutics, Inc. (QNCX): 8-K filed Sep 4, 2026

Form type

8-K

Filing date

Sep 4, 2026

Accession number

0001193125-26-382838

Filer

Quince Therapeutics, Inc. (CIK 1662774)